142 related articles for article (PubMed ID: 35711848)
1. Anticancer Efficacy and Mechanisms of a Dual Targeting of Norepinephrine Transporter and Thyrointegrin αvβ3 Antagonist in Neuroblastoma.
Godugu K; Karakus OO; Fujioka K; Glinsky GV; Mousa SA
J Cancer; 2022; 13(8):2594-2606. PubMed ID: 35711848
[No Abstract] [Full Text] [Related]
2. Discovery of dual targeting PEGylated BG-P
Ozen Karakus O; Godugu K; Mousa SA
Bioorg Med Chem; 2021 Aug; 43():116278. PubMed ID: 34157571
[TBL] [Abstract][Full Text] [Related]
3. Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin αvβ3 Receptors in the Treatment of Neuroblastoma.
Karakus OO; Godugu K; Rajabi M; Mousa SA
J Med Chem; 2020 Jul; 63(14):7653-7662. PubMed ID: 32571015
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel bifunctional thyrointegrin antagonists for neuroblastoma.
Karakus OO; Godugu K; Fujioka K; Mousa SA
Bioorg Med Chem; 2021 Jul; 42():116250. PubMed ID: 34118788
[TBL] [Abstract][Full Text] [Related]
5. Anti-Cancer Activities of Thyrointegrin α
Godugu K; Rajabi M; Mousa SA
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204997
[TBL] [Abstract][Full Text] [Related]
6. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
Bioconjug Chem; 2019 Dec; 30(12):3087-3097. PubMed ID: 31714064
[TBL] [Abstract][Full Text] [Related]
7. Norepinephrine transporter analog benzylguanidine-conjugated nanoparticles for the delivery of paclitaxel in neuroblastoma.
Karakus OO; Godugu K; Salaheldin T; Fujioka K; Mousa SA
Nanomedicine (Lond); 2021 Nov; 16(26):2331-2342. PubMed ID: 34651508
[No Abstract] [Full Text] [Related]
8. Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme.
Godugu K; Hay BA; Glinsky GV; Mousa SA
Neurooncol Adv; 2023; 5(1):vdac180. PubMed ID: 36879662
[TBL] [Abstract][Full Text] [Related]
9. Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management.
Sudha T; Godugu K; Darwish NHE; Nazeer T; Mousa SA
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439224
[TBL] [Abstract][Full Text] [Related]
10. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α
Sudha T; Godugu K; Glinsky GV; Mousa SA
Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453545
[TBL] [Abstract][Full Text] [Related]
11. Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia.
Darwish NHE; Glinsky GV; Sudha T; Mousa SA
Front Oncol; 2021; 11():793810. PubMed ID: 35155195
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Molecules of Benzylguanidine and the Alkylating Group of Melphalan: Synthesis and Effects on Neuroblastoma Cells.
Bruchelt G; Klose C; Lischka M; Brandes M; Handgretinger R; Brueckner R
J Clin Med; 2023 Jul; 12(13):. PubMed ID: 37445504
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin α
Fujioka K; Hay BA; Godugu K; Mousa SA
Front Pharmacol; 2022; 13():902141. PubMed ID: 36518666
[TBL] [Abstract][Full Text] [Related]
14. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Zhang H; Huang R; Cheung NK; Guo H; Zanzonico PB; Thaler HT; Lewis JS; Blasberg RG
Clin Cancer Res; 2014 Apr; 20(8):2182-91. PubMed ID: 24573553
[TBL] [Abstract][Full Text] [Related]
15. Correction to "Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
Bioconjug Chem; 2021 Apr; 32(4):859. PubMed ID: 33689298
[No Abstract] [Full Text] [Related]
16. Correction to "Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
Bioconjug Chem; 2023 Feb; 34(2):453. PubMed ID: 36709499
[No Abstract] [Full Text] [Related]
17. Novel Meta-iodobenzylguanidine-Based Copper Thiosemicarbazide-1-guanidinomethylbenzyl Anticancer Compounds Targeting Norepinephrine Transporter in Neuroblastoma.
Zhang H; Xie F; Cheng M; Peng F
J Med Chem; 2019 Aug; 62(15):6985-6991. PubMed ID: 31283215
[TBL] [Abstract][Full Text] [Related]
18. Nano-Targeting of Thyrointegrin αvβ3 Receptor in Solid Tumors and Impact on Radiosensitization.
Sudha T; Rehman MU; Darwish NHE; Coskun MD; Satti JA; Davis PJ; Mousa SA
Radiat Res; 2021 Oct; 196(4):375-385. PubMed ID: 34260732
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human neuroblastoma cell lines established before and after therapy.
Reynolds CP; Biedler JL; Spengler BA; Reynolds DA; Ross RA; Frenkel EP; Smith RG
J Natl Cancer Inst; 1986 Mar; 76(3):375-87. PubMed ID: 3456456
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors.
Yu D; Jin C; Leja J; Majdalani N; Nilsson B; Eriksson F; Essand M
J Virol; 2011 Dec; 85(24):13114-23. PubMed ID: 21957304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]